PharmaCyte Biotech Inc (PMCB)

[Peacefulwendy]

PMCB is not going to be doing human trials with a new cancer drug that needs to be approved. They are using a delivery system, Cell in a Box (R). The drug being used for targeted delivery, ifiosfomide, has been on the market for years. Additonally, targeted delivery has proven to be less toxic than traditional chemotherapy and in past studies we had better results than the current Gold Standard. Also, the Phase 1 trials scheduled with TD2 for later this year are for pain associated with pancreatic cancer and malignant ascites.

I found the article very interesting but must ensure readers see how it does not relate to studies being done here at PMCB.

This video is a good place for all investors to learn the basics about Cell in a Box technology and our work with Dr Von Hoff and TD2.